For decades, high blood pressure has dominated cardiovascular risk conversations, but this finding flips attention to the lower end of the pressure spectrum — and to an entirely different organ system. Adults with chronically low systolic blood pressure may face a meaningfully elevated susceptibility to allergic rhinitis, one of the most prevalent and underestimated chronic conditions affecting quality of life, productivity, and sleep.
Using a bidirectional two-sample Mendelian randomization framework — a method that exploits naturally occurring genetic variants to approximate causal inference — researchers analyzed 421 independent single-nucleotide polymorphisms (SNPs) associated with systolic blood pressure drawn from genome-wide association study data on the MR-Base platform. Three analytic methods (inverse-variance weighted, weighted median, and MR-Egger regression) converged on a consistent direction: genetically instrumented lower systolic blood pressure was associated with increased odds of allergic rhinitis, with an IVW odds ratio of approximately 0.9997 per unit decrease. Crucially, the reverse analysis found no genetic signal suggesting that allergic rhinitis itself drives blood pressure changes, establishing a directional relationship rather than mere correlation.
This result is notable because Mendelian randomization substantially reduces confounding from lifestyle variables — including smoking and dust exposure, both known to simultaneously affect blood pressure and nasal inflammation. That said, the effect size per SNP unit is modest, and the biological mechanism remains speculative. One plausible pathway involves autonomic nervous system tone: lower vascular resistance may alter mast cell reactivity or mucosal perfusion dynamics in ways that lower the threshold for IgE-mediated nasal responses. This is a single study using summary-level GWAS data, and replication in independent cohorts with measured phenotypes is essential. Still, for clinicians managing patients with both hypotensive tendencies and persistent nasal allergy symptoms, this finding offers a genetic rationale to investigate the two conditions in tandem — a genuinely underexplored clinical intersection.